~49 spots leftby Dec 2025

SIESTA Rehab Education for Stroke Recovery

Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Chicago
No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial aims to help stroke patients recover better by improving their sleep during rehabilitation. It involves training nurses to avoid waking patients unnecessarily and checking for and treating any sleep-related breathing issues. Better sleep can lead to better brain recovery and learning.

Research Team

Eligibility Criteria

This trial is for adults over 18 who've had a stroke and are admitted to the Shirley Ryan AbilityLab. They must be able to consent, follow study procedures, and have medical clearance. It's not for those with serious heart conditions, neurological diseases like MS or Alzheimer's, pregnant/nursing women, people with skin allergies/open wounds, or users of certain cardiac devices.

Inclusion Criteria

Medical clearance from physician
You are currently staying at the Shirley Ryan AbilityLab due to a stroke.
I am 18 years old or older.
See 1 more

Exclusion Criteria

I do not have serious heart conditions or diseases like MS, Alzheimer's, or Parkinson's.
You have a powered heart monitoring or support device implanted, like a pacemaker or defibrillator.
I have skin allergies, irritations, or open wounds.
See 1 more

Treatment Details

Interventions

  • ApneaLink (Diagnostic Test)
  • SIESTA Rehab Education (Behavioral Intervention)
Trial OverviewThe SIESTA program aims to improve sleep during acute stroke rehabilitation by educating nurses on minimizing disruptions and using a protocol called ApneaLink to screen and treat sleep-disordered breathing if it occurs.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: SIESTA RehabExperimental Treatment2 Interventions
Stroke floor on which nurses will be receiving training (SIESTA Rehab Education) on how to minimize nighttime disruptions and batching overnight tasks to preserve sleep for patients hospitalized on that floor. Stroke patients admitted to the SIESTA Rehab Unit will be screening for sleep disordered breathing using ApneaLink. Patients hospitalized on this unit will be approached for consent to wear sensors and actigraphy watches during the hospital stay and after discharge.
Group II: Control UnitActive Control1 Intervention
Patients on this unit will receive usual care for stroke patients as outlined by SRALab. including routine nursing care without any intervention to promote sleep like SIESTA and routing sleep disorders screenings based on clinician judgement. Patients hospitalized on this unit will also be approached for consent to wear sensors and actigraphy watches during the hospital stay and after discharge.

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Chicago

Lead Sponsor

Trials
1,086
Recruited
844,000+
Pete Salzmann profile image

Pete Salzmann

University of Chicago

Chief Executive Officer since 2018

MD from University of Chicago’s Pritzker School of Medicine, MBA from Stanford University’s Graduate School of Business

Anh Nguyen profile image

Anh Nguyen

University of Chicago

Chief Medical Officer

MD from Rutgers New Jersey Medical School, MBA from University of Chicago

Shirley Ryan AbilityLab

Collaborator

Trials
212
Recruited
17,900+
Dr. Pablo Celnik profile image

Dr. Pablo Celnik

Shirley Ryan AbilityLab

Chief Executive Officer since 2023

MD from University of Buenos Aires Faculty of Medical Sciences

Dr. James Sliwa profile image

Dr. James Sliwa

Shirley Ryan AbilityLab

Chief Medical Officer since 2021

DO

Northwestern University

Collaborator

Trials
1,674
Recruited
989,000+
Dr. Jeffrey Sherman profile image

Dr. Jeffrey Sherman

Northwestern University

Chief Medical Officer

MD from Northwestern University

Dr. Alicia Löffler profile image

Dr. Alicia Löffler

Northwestern University

Chief Executive Officer since 2010

PhD from the University of Massachusetts at Amherst, post-doctoral training at Caltech